Tregs in T cell vaccination: Exploring the regulation of regulation

Journal of Clinical Investigation

Volumn 114, Issue 9, 2004, Pages 1227-1232

  Cohen, Irun R ^a   Quintana, Francisco J ^a   Mimran, Avishai ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; EPITOPE; HEAT SHOCK PROTEIN 60; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VACCINE; ANTIGEN; CHAPERONIN; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIERGOTYPIC T LYMPHOCYTE; ANTIIDIOTYPIC T LYMPHOCYTE; CYTOKINE RELEASE; DOWN REGULATION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE CLONE; ONTOGENY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TARGET CELL; UPREGULATION; VACCINATION; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; IMMUNOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHAPERONIN 60; DOWN-REGULATION; HUMANS; MODELS, BIOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; UP-REGULATION; VACCINES;

EID: 15244363969     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200423396     Document Type: Review

References (40)

1. Ben-Nun, A., Wekerle, H., and Cohen, I.R. 1981. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195-199.
2. Ben-Nun, A., Wekerle, H., and Cohen, I.R. 1981. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature. 292:60-61.
3. Cohen, I.R., Holoshitz, J., van Eden, W., and Frenkel, A. 1985. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthtitis. Arthritis Rheum. 28:841-845.
4. Ben-Yehuda, A., et al. 1996. Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice. Lupus. 5:232-236.
5. Elias, D., Tikochinski, Y., Frankel, G., and Cohen, I.R. 1999. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide. Int. Immunol. 11:957-966.
6. Zhang, J. 2002. T-cell vaccination for autoimmune diseases: immunologic lessons and clinical experience in multiple sclerosis. Expert Rev. Vaccines. 1:285-292.
7. Van der Aa, A., et al. 2003. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. Clin. Exp. Immunol. 131:155-168.
8. Correale, J., et al. 2000. T cell vaccination in secondary progressive multiple sclerosis. J. Neuroimmunol. 24:130-139.
9. Kumar, V., Sercarz, E., Zhang, Z., and Cohen, I.R. 2001. T-cell vaccination: from basics to the clinic. Trends Immunol. 22:539-540.
10. Cohen, I.R. 2001. T-cell vaccination for autoimmune disease: a panorama. Vaccine. 20:706-710.
11. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A., and Cohen, I.R. 1988. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 239:181-183.
12. Jiang, H., and Chess, L. 2000. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185-216.
13. Kumar, V., et al. 1997. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159:5150-5156.
14. Hu, D., et al. 2004. Analysis of regulatory CD8 T cells in Qa-1 deficient mice. Nat. Immunol. 5:516-523.
15. Panoutsakopoulou, V., et al. 2004. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J. Clin. Invest. 113:1218-1224. doi: 10.1172/JCI200420772.
16. Vandenbark, A.A., Hashim, G., and Offner, H. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 12:541-544.
17. Kumar, V., Tabibiazar, R., Geysen, H.M., and Sercarz, E. 1995. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154:1941-1950.
18. Naparstek, Y., et al. 1983. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur. J. Immunol. 13:418-423.
19. Vaday, G.G., et al. 2001. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J. Leukoc. Biol. 69:885-892.
20. Lohse, A.W., Mor, F., Karin, N., and Cohen, I.R. 1989. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science. 244:820-822.
21. Russo, C., et al. 1981. Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of 1a-like antigens with monoclonal antibodies. Immunogenetics. 12:267-274.
22. Correale, J., Rojany, M., and Weiner, L.P. 1997. Human CD8+ TCR-αβ(+) and TCR-γ δ (+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms. J. Neuroimmunol. 80:47-64.
23. Mimran, A., et al. 2004. DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response. J. Clin. Invest. 113:924-932. doi: 10.1172/JCI200417772.
24. Waldmann, T.A. 1993. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol. Today. 14:264-270.
25. Mor, F., Reizis, B., Cohen, I.R., and Steinman, L. 1996. IL-2 and TNF receptors as targets of regulatory T-T interactions: isolation and characterization of cytokine receptor-reactive T cell lines in the Lewis rat. J. Immunol. 157:4855-4861.
26. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 101:455-458.
27. Kaufman, B.A., Kolesar, J.E., Perlman, P.S., and Butow, R.A. 2003. A function for the mitochondrial chaperonin Hsp60 in the structure and transmission of mitochondrial DNA nucleoids in Saccharomyces cerevisiae. J. Cell Biol. 163:457-461.
28. Amir-Kroll, H., Nussbaum, G., and Cohen, I.R. 2003. Proteins and their derived peptides as carriers in a conjugate vaccine for streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. J. Immunol. 170:6165-6171.
29. Ohashi, K., Burkart, V., Flohe, S., and Kolb, H. 2000. Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:558-561.
30. Flohe, S.B., et al. 2003. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 170:2340-2348.
31. Zanin-Zhorov, A., Nussbaum, G., Franitza, S., Cohen, I.R., and Lider, O. 2003. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 17:1567-1569.
32. Quintana, F.J., Carmi, P., Mor, F., and Cohen, I.R. 2003. DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J. Immunol. 171:3533-3541.
33. Quintana, F.J., Carmi, P., and Cohen, I.R. 2002. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J. Immunol. 169:6030-6035.
34. Raz, I., et al. 2001. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double- blind, phase II trial. Lancet. 358:1749-1753.
35. Cohen, I.R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today. 13:490-494.
36. Brod, S.A., Purvee, M., Benjamin, D., and Hafler, D.A. 1990. T-T cell interactions are mediated by adhesion molecules. Eur. J. Immunol. 20:2259-2268.
37. Cohen, I.R. 2000. Discrimination and dialogue in the immune system. Semin. Immunol. 12:215-279, 321-323.
38. Levy, L., Enk, C.D., Zipris, D., and Cohen, I.R. 1994. Protection of mice against mycobacterial infection by lymphoid cell vaccination. Isr. J. Med. Sci. 30:22-25.
39. Cantor, H. 2004. Reviving suppression? Nat. Immunol. 5:347-348.
40. Cohen, I.R. 2000. Tending Adam's Garden: Evolving the Cognitive Immune Self. Academic Press. London, United Kingdom. 266 pp.